## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `selank-glp1-gut` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/selank-glp1-gut/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-glp1-gut/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-glp1-gut/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/selank-glp1-gut/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-glp1-gut/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/selank-glp1-gut/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `selank-glp1-gut` v2 · content_hash `2b584689f9b6a81d…` · thread_head genesis · 25 DIVs - **thesis (c1):** GLP-1 agonists increase risk of gastroparesis diagnoses compared with other weight-loss agents in observational human data. - c2 [human/active] Selank showed anxiolytic effects comparable to low-dose benzodiazepines in Russian human GAD trials, with some reports of cognitive enhancement. - c4 [human/active] GLP-1 agonists slow gastric emptying via direct receptor action, contributing to both therapeutic and adverse GI effects. - c3 [mechanistic/active] No human or animal studies test Selank against GLP-1-induced gastroparesis or delayed gastric emptying. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/selank-glp1-gut/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/selank-glp1-gut/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `selank-glp1-gut` - **title:** Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs - **url:** https://miscsubjects.com/a/selank-glp1-gut - **register:** source_ledger - **updated:** 2026-07-17T02:41:37.686Z - **tags:** peptide, matrix ## Body ## What's breaking down if you have GLP-1 gut damage / gastroparesis GLP-1 receptor agonists slow gastric emptying as part of their action on appetite and blood sugar. In some users this leads to persistent delayed emptying that resembles or triggers gastroparesis symptoms such as nausea, bloating, early fullness, and vomiting. Human observational data link the drugs to higher rates of diagnosed gastroparesis compared with other weight-loss agents (human|preclinical). The effect is often dose-dependent and more noticeable early in treatment before partial tachyphylaxis occurs. Chronic gut slowing can also raise background stress signals that feed into the gut-brain axis. If your daily experience includes heightened anxiety or non-restorative arousal on top of the mechanical slowdown, that neurochemistry layer becomes part of what keeps failing. ## Why Selank might help you 1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name. 2. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. 3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation. 4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain. Russian human trials in patients with generalized anxiety disorder showed Selank produced rapid or gradual reductions in Hamilton Anxiety Rating Scale scores comparable to low-dose benzodiazepines, with added cognitive or stimulatory effects reported in some responders (human). Preclinical rat work links it to changes in GABA receptor subunit expression and downstream gene regulation in frontal cortex (preclinical). No human or animal data directly test Selank against GLP-1-induced gastroparesis or delayed gastric emptying. ## Why GLP-1 agonists (class) matters for you GLP-1 agonists deliver metabolic benefit through appetite suppression and improved glycemic control. They also slow gastric emptying, which contributes to both the desired weight-loss effect and the unwanted gut-slowing tradeoff. In users who develop symptomatic gastroparesis, the drug is suppressing a motility signal rather than reducing mechanical load on the gut. Observational human studies report elevated risk of gastroparesis diagnoses (roughly 3–4 times higher than comparator drugs in one analysis), though absolute rates remain low and symptoms often improve after dose reduction or discontinuation (human). ## How these fit together Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - Selank → anxiety / neurochemistry Selank addresses the anxiety/neurochemistry layer that can accompany or amplify gut symptoms from GLP-1 agonists. The agonists themselves act through metabolic and motility suppression. The two do not overlap in mechanism; any perceived fit would come from managing the secondary stress response while the primary drug effect is adjusted by a clinician. ## What the evidence actually shows Human trials for Selank exist only in Russian-language studies of generalized anxiety disorder and neurasthenia; sample sizes are modest and Western replication is absent (human). Rat studies demonstrate gene-expression shifts consistent with GABA modulation (preclinical). No trials examine Selank in gastroparesis or GLP-1 users. GLP-1 gastroparesis links rest on observational cohorts, case reports, and known pharmacology of delayed emptying; randomized data isolating gastroparesis incidence are limited (human). Evidence inventory: approximately 8–10 human Selank anxiety trials or analyses versus zero direct human data on the Selank–GLP-1 gut cross; multiple human observational and mechanistic GLP-1 studies; scattered anecdotal reports on forums. ## What scientists say Published reviews note Selank’s anxiolytic profile is comparable to benzodiazepines without sedation or dependence in the available Russian data, yet call for larger Western trials (human). Gastroenterology literature states that GLP-1 agonists reliably delay gastric emptying and that this mechanism explains both benefit and certain adverse GI events; most cases linked to the drugs appear reversible upon discontinuation (human). ## What people say on Reddit Anecdotal threads describe Selank producing a noticeable drop in background anxiety or “anxious gut feeling” within days for some users with GAD or IBS-like symptoms; others report transient side effects such as heart-rate changes or nausea on first doses (anecdotal). No widespread reports tie Selank specifically to GLP-1 gastroparesis relief. ## What people say on X Posts echo the Reddit pattern: users mention calmer baseline arousal or improved stress tolerance with Selank, sometimes in contexts of gut-brain symptoms, but lack controlled context or long-term tracking (anecdotal). ## What we do not know No data exist on whether Selank alters gastric emptying, interacts with GLP-1 agonists, or changes gastroparesis outcomes in humans or animals. Long-term safety, optimal duration, and effects in patients already experiencing drug-induced gut slowing remain unstudied. ## Safety and limits Selank has been described in Russian clinical use as well-tolerated with minimal sedation. Human data outside Russia are sparse. GLP-1 agonists carry documented GI risks including gastroparesis; any peptide discussion occurs against that background. All claims here are evidence-graded only; nothing constitutes medical advice. ## Claims (4) - **c3** [mechanistic w=0.3] No human or animal studies test Selank against GLP-1-induced gastroparesis or delayed gastric emptying. - who_claims: grok/grok-4.3 - **c1** [human w=0.8] GLP-1 agonists increase risk of gastroparesis diagnoses compared with other weight-loss agents in observational human data. - who_claims: grok/grok-4.3 - sources: s1, s5 - **c2** [human w=0.8] Selank showed anxiolytic effects comparable to low-dose benzodiazepines in Russian human GAD trials, with some reports of cognitive enhancement. - who_claims: grok/grok-4.3 - sources: s10, s11, s12 - **c4** [human w=0.8] GLP-1 agonists slow gastric emptying via direct receptor action, contributing to both therapeutic and adverse GI effects. - who_claims: grok/grok-4.3 - sources: s19, s23 ## Voxel graph (4 atoms · 11 edges) - full graph: https://miscsubjects.com/api/articles/selank-glp1-gut/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (7) - chain valid: yes · head: `3f9ae15f42875de7` ### s1 · pubmed · ok - title: Comparing the risk of gastroparesis following different ... - url: https://pmc.ncbi.nlm.nih.gov/articles/PMC11966946/ - summary: Observational comparison of gastroparesis risk with semaglutide. - quote: In individuals with obesity and no T2D, those treated with semaglutide had significantly higher risk of developing gastroparesis than ... - claim_ids: c1 - hash: `b030413df5d8577c` ### s5 · pubmed · ok - title: Risk of Gastrointestinal Adverse Events Associated With ... - url: https://www.natap.org/2023/HIV/100923_01.htm - summary: Large cohort risk estimates for GLP-1 gastroparesis. - quote: Gastroparesis was seen at a rate of about 10 cases per 1,000 semaglutide users... - claim_ids: c1 - hash: `a2dc8ddf5e7efccc` ### s10 · pubmed · ok - title: Peptide Selank Enhances the Effect of Diazepam in Reducing ... - url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/ - summary: Russian clinical comparison of Selank anxiolytic activity. - quote: Clinical studies have shown that the anxiolytic effect of Selank is comparable to the effect of low doses of the benzodiazepine tranquilizers... - claim_ids: c2 - hash: `8e1562f65d44f14a` ### s11 · pubmed · http_403 - title: P-1114 - Rapid and slow response during treatment of ... - url: https://www.sciencedirect.com/science/article/pii/S0924933812752811 - summary: Selank response kinetics in GAD patients. - quote: 40% of patients were rapid responders... HARS mean total score reduced from 20.3 to 7.0 (p < 0.01). - claim_ids: c2 - hash: `02eb51f12dfbd09b` ### s12 · review · ok - title: Selank for Anxiety: Evidence, Mechanism, Realistic ... - url: https://drlewis.com/selank-for-anxiety/ - summary: Summary of Russian Selank human data and limitations. - quote: The study by Zozulia and colleagues found Selank effective for generalized anxiety disorder therapy... - claim_ids: c2 - hash: `e94b729f05492e24` ### s19 · pubmed · ok - title: GLP-1 receptor agonists and delayed gastric emptying - PMC - url: https://pmc.ncbi.nlm.nih.gov/articles/PMC11620716/ - summary: Mechanistic review of GLP-1 gastric effects. - quote: GLP-1 receptor agonists... may slow down gastric emptying. - claim_ids: c4 - hash: `d321008a9f09c65e` ### s23 · pubmed · ok - title: Effects of GLP-1 and Its Analogs on Gastric Physiology in ... - url: https://pubmed.ncbi.nlm.nih.gov/32077010/ - summary: Human physiology data on GLP-1 gastric slowing. - quote: Human studies show that infusion of GLP-1 results in slowing of gastric emptying... - claim_ids: c4 - hash: `3f9ae15f42875de7` ## Provenance (2 model passes) - chain valid: yes · head: `cb4fdbbc25845639` - write · grok/grok-4.3 · 2026-06-30T00:44 · hash `2df2a2c0c7ba` - voxel_divide · owner · 2026-07-17T02:41 · hash `cb4fdbbc2584` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/selank-glp1-gut/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/selank-glp1-gut/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"selank-glp1-gut","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest selank-glp1-gut|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim selank-glp1-gut|tier|assertion` - **iMessage ask:** `selank-glp1-gut|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `selank-glp1-gut` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-glp1-gut/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-glp1-gut/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*